Renew Your Membership

Erik Magnus Ohman, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Xylocor Therapeutics(SIGNIFICANT), Milestone Pharmaceuticals(MODEST), Cytokinetics(MODEST) RESEARCH/RESEARCH GRANTS: Chiesi(MODEST), Chiesi USA(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Otsuka Pharmaceutical Co.(SIGNIFICANT)

View Full Disclosure